{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:19:14Z","timestamp":1672982354325},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T00:00:00Z","timestamp":1304985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2011.7","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T14:08:59Z","timestamp":1305036539000},"page":"e6-e6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacogenomic testing and outcome among depressed patients in a tertiary care outpatient psychiatric consultation practice"],"prefix":"10.1038","volume":"1","author":[{"given":"J R","family":"Rundell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Harmandayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Staab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,10]]},"reference":[{"key":"BFtp20117_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780195367294.001.0001","volume-title":"Psychiatric Pharmacogenomics","author":"D Mrazek","year":"2010","unstructured":"Mrazek D . Psychiatric Pharmacogenomics. Oxford University Press: New York, 2010."},{"key":"BFtp20117_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/pds.1367","volume":"16","author":"R Paulose-Ram","year":"2007","unstructured":"Paulose-Ram R, Safran MA, Jonas BS, Quiping G, Orwig D . Trends in psychotropic medication use among US adults. Pharmacoepidemiol Drug Saf 2007; 16: 560\u2013570.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"BFtp20117_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ajmg.b.30816","volume":"150B","author":"DA Mrazek","year":"2009","unstructured":"Mrazek DA, Rush AJ, Biernacka JM, O\u2019Kane DJ, Cunningham JM, Wieben ED et al. 5-HTTLPR variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 341\u2013351.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFtp20117_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/archpsyc.65.11.1296","volume":"65","author":"R Kohen","year":"2008","unstructured":"Kohen R, Cain KC, Mitchell PH, Becker K, Buzaitis A, Millard SP et al. Association of serotonin transporter gene polymorphisms with poststroke depression. Arch Gen Psychiatry 2008; 65: 1296\u20131302.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp20117_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.psym.2010.12.023","volume":"52","author":"JR Rundell","year":"2011","unstructured":"Rundell JR, Staab JP, Shinozaki G, Saad-Pendergrass D, Moore K, McAlpine D et al. Pharmacogenomic testing in a tertiary care outpatient psychosomatic medicine practice. Psychosomatics 2011; 52: 141\u2013146.","journal-title":"Psychosomatics"},{"key":"BFtp20117_CR6","unstructured":"Rundell JR, Staab JP . Management recommendation impacts of pharmacogenomic testing in a tertiary care outpatient psychosomatic medicine practice. Psychosomatic Med (in press)."},{"key":"BFtp20117_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.psychres.2006.03.020","volume":"149","author":"A Seretti","year":"2007","unstructured":"Seretti A, Mandelli L, Lorenzi C, Pirovano P, Olgiati P, Colombo C et al. Serotonin transporter gene influences the time course of improvement of core depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders. Psychiatry Res 2007; 149: 185\u2013193.","journal-title":"Psychiatry Res"},{"key":"BFtp20117_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/14622416.9.7.935","volume":"9","author":"E Lin","year":"2008","unstructured":"Lin E, Chen PS . Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics 2008; 9: 935\u2013946.","journal-title":"Pharmacogenomics"},{"key":"BFtp20117_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.mp.4001926","volume":"12","author":"A Serretti","year":"2007","unstructured":"Serretti A, Kato M, DeRonchi D, Kinoshita T . Meta-analysis of serotonin transporter gene polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007; 12: 247\u2013257.","journal-title":"Mol Psychiatry"},{"key":"BFtp20117_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.psym.2010.12.013","volume":"52","author":"JR Rundell","year":"2011","unstructured":"Rundell JR, Staab JP, Shinozaki G, McAlpine D . Serotonin transporter gene polymorphism (5-HTTLPR) associations with number of psychotropic medication trials in a tertiary care outpatient psychiatric consultation practice. Psychosomatics 2011; 52: 147\u2013153.","journal-title":"Psychosomatics"},{"key":"BFtp20117_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606\u2013613.","journal-title":"J Gen Intern Med"},{"key":"BFtp20117_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.biopsych.2006.11.010","volume":"61","author":"PF Sullivan","year":"2007","unstructured":"Sullivan PF . Spurious genetic associations. Biol Psychiatry 2007; 61: 1121\u20131126.","journal-title":"Biol Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp20117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp20117","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp20117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:30:59Z","timestamp":1672954259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp20117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,10]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5]]}},"alternative-id":["BFtp20117"],"URL":"https:\/\/doi.org\/10.1038\/tp.2011.7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,10]]},"assertion":[{"value":"17 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research conducted in this study was sponsored by an unrestricted industry grant to Mayo Clinic, Rochester Minnesota, USA, from AssureRx.The administration of this support was in accordance with Mayo Clinic policy on industry relations, and coordinated by the Mayo Clinic Industry Relations Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}